Earnings

Oracle Corporation is undergoing a remarkable strategic pivot, transitioning from its traditional software roots to become a formidable force in...

Marvell Technology finds itself at the center of a confusing narrative for market participants. On one hand, the semiconductor firm...

German media conglomerate ProSiebenSat.1 Media finds itself navigating turbulent waters, caught between a struggling core advertising business and promising growth...

UnitedHealth Group has announced a significant reduction of its Medicare Advantage footprint, confirming it will exit 109 county markets for...

The biotechnology sector is witnessing one of its most compelling growth narratives with Madrigal Pharmaceuticals, whose shares have delivered extraordinary...

The mixed-performance pattern of Textron's stock presents investors with a compelling puzzle. While the industrial conglomerate delivered impressive quarterly results,...

The unprecedented demand for artificial intelligence infrastructure has propelled memory chip manufacturer Micron to deliver staggering financial results. Following its...

Investors in Cytokinetics are experiencing heightened tension as the biotechnology firm navigates a complex approval pathway for its cardiac treatment...

The upcoming quarterly report from Qurate Retail represents what could be the final opportunity for a meaningful reversal in the...

Theriva Biologics has initiated a severe corporate restructuring program, eliminating 32% of its global workforce—a reduction of seven positions—in a...